RxDoctor Payments Data

Amber Daugherty, MD

Family Medicine · Mount Verono, OHNPI 1124273875

Payments from drug & device makers

$1,731in general payments, 2019–2025

Across 104 payments — averaging $16.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$245
  • AbbVie$234
  • Amgen$166
  • AstraZeneca$147
  • Astellas Pharma US Inc$125
  • Abbott$124
  • plus $691 from 16 others

What the payments were for

  • Food & beverage$1,731100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,731 in reported general payments places this provider in the 70th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$56,105
Medicare patients
192
Services billed
859

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide45$50,786
JardianceEmpagliflozin45$50,118
JanuviaSitagliptin Phosphate38$34,712
EliquisApixaban30$26,589
MounjaroTirzepatide16$26,319
TrulicityDulaglutide22$24,261
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog25$16,789
Breo ElliptaFluticasone/Vilanterol33$16,563
XareltoRivaroxaban15$15,389
RybelsusSemaglutide12$15,119
FarxigaDapagliflozin Propanediol11$12,131
SymbicortBudesonide/Formoterol Fumarate17$8,545
InvokanaCanagliflozin11$8,535
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog14$6,926
Lantus SolostarInsulin Glargine,hum.Rec.Anlog40$5,205

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$245$65,90557 claims
Lilly USA, LLCMounjaro, Trulicity$60$50,58038 claims
Boehringer IngelheimJardiance$96$50,11845 claims
MerckJanuvia$64$34,71238 claims
PfizerEliquis$82$26,58930 claims
Johnson & JohnsonXarelto, Invokana$45$23,92326 claims
AstraZenecaFarxiga, Symbicort$147$20,67728 claims
GSKBreo Ellipta$33$16,56333 claims
Sanofi-aventis U.S. LLCLantus$24$94515 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Mount Verono

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →